Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Tag: revance therapeutics

All

Popular
Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

  • Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

  • Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management

  • FDA Accepts Revance Resubmission for Frown Line Treatment

  • FDA Approves Revance Daxxify for Frown Lines

  • Studies Show Efficacy of Daxxify to Treat Frown Lines

  • Revance Publishes 2 Papers on Daxxify Injectable

  • Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Latest
Sorry, No Posts Found

All

Latest
AI Model Predicts Blood Loss in High-Volume Liposuction, Study Finds

AI Model Predicts Blood Loss in High-Volume Liposuction, Study Finds

A machine learning model analyzed data from more than 700 procedures and predicted intraoperative blood loss with 94% accuracy

  • 1 in 7 Americans Plan To Use GLP-1s in 2026, Survey Finds

    1 in 7 Americans Plan To Use GLP-1s in 2026, Survey Finds

  • Merz Aesthetics Launches Xeomin and Radiesse in China

    Merz Aesthetics Launches Xeomin and Radiesse in China

  • Nemolizumab Shows Early Relief of Itch and Sleep Disruption in Chronic Skin Conditions

    Nemolizumab Shows Early Relief of Itch and Sleep Disruption in Chronic Skin Conditions

Sorry, No Posts Found

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved